1
|
Liu R, Yu ZC, Xiao CX, Xiao SF, He J, Shi Y, Hua YY, Zhou JM, Zhang GY, Wang T, Jiang JY, Xiong DX, Chen Y, Xu HB, Yun H, Sun H, Pan TT, Wang R, Zhu SM, Huang D, Liu YJ, Hu YH, Ren XR, Shi MF, Song SZ, Luo JM, Liu J, Zhang J, Xu F. [Different methods in predicting mortality of pediatric intensive care units sepsis in Southwest China]. Zhonghua Er Ke Za Zhi 2024; 62:204-210. [PMID: 38378280 DOI: 10.3760/cma.j.cn112140-20231013-00282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/22/2024]
Abstract
Objective: To investigate the value of systemic inflammatory response syndrome (SIRS), pediatric sequential organ failure assessment (pSOFA) and pediatric critical illness score (PCIS) in predicting mortality of pediatric sepsis in pediatric intensive care units (PICU) from Southwest China. Methods: This was a prospective multicenter observational study. A total of 447 children with sepsis admitted to 12 PICU in Southwest China from April 2022 to March 2023 were enrolled. Based on the prognosis, the patients were divided into survival group and non-survival group. The physiological parameters of SIRS, pSOFA and PCIS were recorded and scored within 24 h after PICU admission. The general clinical data and some laboratory results were recorded. The area under the curve (AUC) of the receiver operating characteristic curve was used to compare the predictive value of SIRS, pSOFA and PCIS in mortality of pediatric sepsis. Results: Amongst 447 children with sepsis, 260 patients were male and 187 patients were female, aged 2.5 (0.8, 7.0) years, 405 patients were in the survival group and 42 patients were in the non-survival group. 418 patients (93.5%) met the criteria of SIRS, and 440 patients (98.4%) met the criteria of pSOFA≥2. There was no significant difference in the number of items meeting the SIRS criteria between the survival group and the non-survival group (3(2, 4) vs. 3(3, 4) points, Z=1.30, P=0.192). The pSOFA score of the non-survival group was significantly higher than that of the survival group (9(6, 12) vs. 4(3, 7) points, Z=6.56, P<0.001), and the PCIS score was significantly lower than that of the survival group (72(68, 81) vs. 82(76, 88) points, Z=5.90, P<0.001). The predictive value of pSOFA (AUC=0.82) and PCIS (AUC=0.78) for sepsis mortality was significantly higher than that of SIRS (AUC=0.56) (Z=6.59, 4.23, both P<0.001). There was no significant difference between pSOFA and PCIS (Z=1.35, P=0.176). Platelet count, procalcitonin, lactic acid, albumin, creatinine, total bilirubin, activated partial thromboplastin time, prothrombin time and international normalized ratio were all able to predict mortality of sepsis to a certain degree (AUC=0.64, 0.68, 0.80, 0.64, 0.68, 0.60, 0.77, 0.75, 0.76, all P<0.05). Conclusion: Compared with SIRS, both pSOFA and PCIS had better predictive value in the mortality of pediatric sepsis in PICU.
Collapse
Affiliation(s)
- R Liu
- Department of Pediatric Critical Care, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing 400014, China
| | - Z C Yu
- Department of Pediatric Critical Care, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing 400014, China
| | - C X Xiao
- Department of Pediatric Critical Care, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing 400014, China
| | - S F Xiao
- Department of Pediatric Critical Care, Kunming Children's Hospital, Kunming 650103, China
| | - J He
- Department of Pediatric Critical Care, Kunming Children's Hospital, Kunming 650103, China
| | - Y Shi
- Department of Pediatric Critical Care, the First People's Hospital of Liangshan Yi Autonomous Prefecture, Xichang 615099, China
| | - Y Y Hua
- Department of Pediatric Critical Care, the First People's Hospital of Liangshan Yi Autonomous Prefecture, Xichang 615099, China
| | - J M Zhou
- Department of Pediatric Critical Care, the First People's Hospital of Liangshan Yi Autonomous Prefecture, Xichang 615099, China
| | - G Y Zhang
- Department of Pediatric Critical Care, Chengdu Women's and Children's Central Hospital, Chengdu 610073, China
| | - T Wang
- Department of Pediatric Critical Care, Chengdu Women's and Children's Central Hospital, Chengdu 610073, China
| | - J Y Jiang
- Department of Pediatric Critical Care, Chongqing University Three Gorges Hospital, Chongqing 400030, China
| | - D X Xiong
- Department of Pediatric Critical Care, Chongqing University Three Gorges Hospital, Chongqing 400030, China
| | - Y Chen
- Department of Pediatric Critical Care, Guizhou Provincial Children's Hospital, Zunyi 563099, China
| | - H B Xu
- Department of Pediatric Critical Care, Guizhou Provincial Children's Hospital, Zunyi 563099, China
| | - H Yun
- Department of Pediatric Critical Care, Guizhou Provincial Children's Hospital, Zunyi 563099, China
| | - H Sun
- Department of Pediatric Critical Care, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - T T Pan
- Department of Pediatric Critical Care, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - R Wang
- Department of Pediatric Critical Care, Yuxi Children's Hospital, Yuxi 653199, China
| | - S M Zhu
- Department of Pediatric Critical Care, Yuxi Children's Hospital, Yuxi 653199, China
| | - D Huang
- Department of Pediatric Critical Care, Guizhou Provincial People's Hospital, Guiyang 550499, China
| | - Y J Liu
- Department of Pediatric Critical Care, Guizhou Provincial People's Hospital, Guiyang 550499, China
| | - Y H Hu
- Department of Pediatric Critical Care, Sichuan Provincial Maternity and Child Health Hospital, Chengdu 610045, China
| | - X R Ren
- Department of Pediatric Critical Care, Sichuan Provincial Maternity and Child Health Hospital, Chengdu 610045, China
| | - M F Shi
- Department of Pediatric Critical Care, the First People's Hospital of Yibin, Yibin 644099, China
| | - S Z Song
- Department of Pediatric Critical Care, the First People's Hospital of Yibin, Yibin 644099, China
| | - J M Luo
- Department of Pediatric Critical Care, the First People's Hospital of Yibin, Yibin 644099, China
| | - J Liu
- Department of Pediatric Critical Care, Nanchong Central Hospital, Nanchong 637003, China
| | - J Zhang
- Department of Pediatric Critical Care, Nanchong Central Hospital, Nanchong 637003, China
| | - F Xu
- Department of Pediatric Critical Care, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing 400014, China
| |
Collapse
|
2
|
Xie SC, Yang YJ, Zhang JQ, Zhou S, Xie SW, Hua YY. HOXD-AS1: a novel oncogenic long intergenic non-coding RNA in humans. Eur Rev Med Pharmacol Sci 2020; 23:2898-2907. [PMID: 31002165 DOI: 10.26355/eurrev_201904_17568] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Long non-coding RNAs are an emerging special class of regulatory RNAs with more than 200 nucleotides that play vital roles in gene regulation, metabolism, drug resistance, cell differentiation, and other processes. These RNAs were also reported to be dysregulated in human disease, especially malignant tumors. However, the underlying mechanisms remain elusive. HOXD cluster antisense RNA 1 (HOXD-AS1), a recently discovered long non-coding RNA, is overexpressed in many cancers. We now review recent advances in understanding the function, role, regulation, and oncogenic properties of HOXD-AS1. MATERIALS AND METHODS A systematic literature review in PubMed of HOXD-AS1 and cancer-related articles in English, published until June 2018, was conducted. RESULTS The literature suggests that HOXD-AS1 is an oncogene that regulates diverse physiological and cellular processes such as proliferation, apoptosis, migration, invasion, metastasis, chemoresistance, epithelial to mesenchymal transition, and stem cell formation by interacting with various regulatory proteins and sequestering several microRNAs such as miR-608, miR-130a, and miR-217. CONCLUSIONS HOXD-AS1 may be a prognostic biomarker and potential therapeutic target for various tumor diagnosis and treatment.
Collapse
Affiliation(s)
- S C Xie
- Department of Hepatobiliary Surgery, Haikou People's Hospital/Affiliated Haikou Hospital, Xiangya School of Medicine, Central South University, Haikou, Hainan, P.R. China.
| | | | | | | | | | | |
Collapse
|